biotech / news / / Crypto News
Anthropic Trust appointed Vas Narasimhan, CEO of Novartis, to Anthropic’s board of directors on April 14, 2026.
Vas Narasimhan is the first pharma executive appointed to Anthropic’s board of directors.
KEY POINTS
- Trust-appointed directors now hold a majority on Anthropic's board for the first time.
- The Long-Term Benefit Trust can direct Anthropic’s board to prioritize responsible AI development.
- Anthropic's Claude for Healthcare initiative has launched partnerships with Eli Lilly, Novo Nordisk, and Genmab.
- Anthropic’s annualized revenue now exceeds $30 billion, with an IPO potentially valuing it at $380 billion.
COMPANIES
Summarized by Newsio from Crypto News. How we summarize →